Evaluating Advances in AML Therapy and Critical Trial Analysis

This week, we continue our series focusing on acute myeloid leukemia. In this episode, we talk about maintenance therapies in AML.

Episode contents:

- A recap of cytarabine consolidation

- Why do we do maintenance therapy?

- What are hypomethylating agents and how do they work?

- Important targeted agents that play a role in maintenance therapy

****This episode is sponsored by our Global Research Partners! Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast